therapeutic modalities: crrt, sled, pd...
TRANSCRIPT
![Page 1: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/1.jpg)
unesp
Daniela Ponce
Therapeutic Modalities: CRRT, SLED, PD
PD
BOTUCATU SCHOOL OF MEDICINE, SAO PAULO STATE, BRAZIL
16 th CRRT, San Diego, California 2011
![Page 2: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/2.jpg)
Case Study
A 55-year-old man was victim to a massive attack by Africanized bees (>500 beestings) in a rural area in Sao Paulo, Brazil.
Day 1: On admission to hospital, widespread erythematous and painful papuleswere found on his body and he was discharged from the hospital after oralmedication.
Day 6: He was admitted to a emergency medical assistance, complaining ofedema, urine volume reduction and weakness. No laboratory evaluation wasperformed and he was discharged from hospital.
Day 10: The patient was tranferred from another hospital 24 h after admissionfor high volume vomit, urine volume decrease and altered mental status. On PE hewas somnolent, emaciated 2, pale, BP= 160/100 mmHg, HR= 105 per minute andhis lungs with basilar rales (sat=90% in spontaneuos ventilation). The otheraspects of the PE were unremarkable.
![Page 3: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/3.jpg)
• His blood laboratory examination showed haematocrit 16%;haemoglobin, 5.9 g/dl, serum creatinine 27 mg/dl; blood ureanitrogen, 221 mg/dl; serum potassium, 7.8 mEq/l, serum pH 7.15,bic 5, total CO2 18 mmol/L.
• He was transferred to the Intensive Care Unit (ICU) andsupportive measures were started (transfusion, oxygen therapyand bicarbonate)
• APACHE 2 = 15.6 ATN-ISS= 0.41
• output urine after 6 h = 40 ml
• We are asked to evaluate him at the same day because of labexams and low urine output
![Page 4: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/4.jpg)
Start dialylis now
Volume overload
Metabolic acidosis
Hyperkalemia
Uremic state
Which dialysis method ?
CRRT SLED iHD PD
![Page 5: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/5.jpg)
Continuous PD using a flexible catheter and a cycler was performed
24 hours 19 cycles 2 liters/cycle 1.5% glucose
Clinical and lab improvements were observed after 2 days oftreatment, but diuresis recovery was recorded only 20 days
PD was interrupted after 23 days
Seventy-one days after the attack he had full recovery of renalfunction
![Page 6: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/6.jpg)
1- Is it used?
2- Why to indicate it ?
3- For whom?
4- How to prescribe it?
5- Which is the ideal dose ?
6- Is it better or worsen than other methods?
7- What is the real role of PD in AKI?
Peritoneal Dialysis in AKI
![Page 7: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/7.jpg)
BEST Study * Latin America *0
20
40
60
80
100 %
Europe **
1. Is it used ?
CRRTHD
SLEDPD
* Uchino. JAMA, 2005** Ricci. NDT, 2006
SLANH***: 35% in Latin America
*** Lombardi. WCN 2007
![Page 8: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/8.jpg)
0
20
40
60
80
1997 1998 1999 2000
HC - SP
Lima EQ. ASN, 2002
% %
HD PD CRRT
Botucatu School
Barretti P. Renal Failure, 1997Balbi AL. JBN, 2002. Balbi AL. No published
Methods of dialysis in Brazil
PD is still usedfor AKI despiteconcerns aboutits inadequacy
0
20
40
60
80
1997 2004 2006 2008 2009 2010
![Page 9: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/9.jpg)
1- Is it used?
2- Why to indicate it ?
3- For whom?
4- How to prescribe it?
5- Which is the ideal dose ?
6- Is it better or worsen than other methods?
7- What is the real role of PD in AKI?
Peritoneal Dialysis in AKI
![Page 10: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/10.jpg)
• simple technique
• no anticoagulation
• low risk of bleeding
• hemodynamically unstable patients
• low risk of electrolyte disorders
• less expansive than CRRT
Advantages of PD
2. Why ?
![Page 11: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/11.jpg)
Advantages and disavantages
For a selected group of AKI
![Page 12: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/12.jpg)
1- Is it used?
2- Why to indicate it ?
3- For whom?
4- How to prescribe it?
5- Which is the ideal dose ?
6- Is it better or worsen than other methods?
7- What is the real role of PD in AKI?
Peritoneal Dialysis in AKI
![Page 13: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/13.jpg)
![Page 14: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/14.jpg)
utilizar solamente em algunassituaciones hemodinâmicas
no utilizar en el catabolismo severo
Choice of dialysis method in AKI
Withoutindication
• recent abdominal or cardiothoracic surgery
• severe hyperkalemia
• severe respiratory failure
PD
• Indications and contra-indications for each method
• hemodinamic stability and hypercatalism
• nephrology experience
Unstable hemodinamic and
hypercatabolic patients?¿
No use in very unstable patients
No use in severe hypercatabolic patients
![Page 15: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/15.jpg)
Our patient
Volume overloadMetabolic acidosis
HyperkalemiaUremic state
no respiratory failureno changes in ECGno recent surgeriesno unstable hemodinamicallysevere hypercatabolic
can be treated with PD
![Page 16: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/16.jpg)
1- Is it used?
2- Why to indicate it ?
3- For whom?
4- How to prescribe it?
5- Which is the ideal dose ?
6- Is it better or worsen than other methods?
7- What is the real role of PD in AKI?
Peritoneal Dialysis in AKI
![Page 17: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/17.jpg)
For decreasing complications
and improving efficciency
• flexible catheter (1 o 2 “cuffs”)
• automated method - cycler
• continuous DP
![Page 18: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/18.jpg)
Fast exchanges h/h,sessions of 16-20 hs,2-3xx/weekly
exchanges with dweltime longer (2-6 hs)
Fast exchanges (30 min)during 8-10 hs, withresidual volum (0.5-1 l) (>solut3 clearance)
HVPD
Fast exchanges(h/h), sessions of24 h, 7xx a week
![Page 19: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/19.jpg)
![Page 20: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/20.jpg)
Dialysis protocols for CPD
![Page 21: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/21.jpg)
Metabolic control and fluid balance
Gabriel DP. PDI, 2007
![Page 22: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/22.jpg)
Creatinine clearance/session (ml/min) 15.8 ± 4.16Urea nitrogen clearance/session (ml/min) 17.3 ± 5.01
Prescribed Kt/V
per session 0.65
weekly 4.5
Delivered Kt/V
per session 0.55 ± 0.12a a
weekly 3.85 ± 0.62a a
Solute Reduction Index (%) 41 ± 9.9
a= p>0.05 from prescribed Kt/V
Variable Median ± SD
Dialysis dose parameters
![Page 23: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/23.jpg)
17%
7%
86%
23%
13%
7%
57%
Complications Outcome
no complications peritonitis
mechanical
death
recovery
no recoverymethod change
CPD is an effective methodfor treating AKI patients
![Page 24: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/24.jpg)
Our patient
• Continuous PD: 24 h
• High Volume PD: 38 l
• Cycler
• Flexible catheter
• There are not complications: mechanic, metabolic, infectious
![Page 25: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/25.jpg)
Cr levels mg /dl
BUN levels mg /dl
Urine output ml/day
tempo em dias
tempo - dias
-50
50
150
250
0
2000
4000
6000
0 20 40 60 80
0
10
20
30
Follow up
![Page 26: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/26.jpg)
Prescribed Kt/V = 0.65
K=? volume of dialysis solution prescribed in 24 hours (mL) _ 0.60 (considering the D/P relationship for dwel time between 30 and 60 min)
t = 1 treatment duration (24 h = 1 day)
V = 35l patient urea distribuition volume (Watson formule)
Weigh = 76 kg (estimated 8 kg of edema) 68 kg V = 35 l K=38 l
The number of dialysis solution exchanges in 24 hours was obtained by dividingthe K value by 2 L (infusion volume)
Total duration of 1 session: 24 hoursInflow time = 10 minOutflow time= 20 minDwell time= 45 mimGlicose concentration = 1.5 %total exchanges/session= 19Total dialysate volume= 38 lFlow rate= 26.4 ml/min
Prescription
Our patient
![Page 27: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/27.jpg)
Calcutating Peritoneal Dialysis Dose:
Delivered Kt/V
Kt/V = [mean dialysate urea nitrogen (mg/dL) / mean serum urea nitrogen
pre andpost dialysis (mg/dL)] _ [drained 24-hour volume (mL) /patient urea
distribution volume (mL)].
![Page 28: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/28.jpg)
Dialysis dose
delivered Kt/V UF (ml) BF (ml) session weekly session day
0,54 4,2 1170 +8800,57 4,5 1350 +6550,61 1480 +3200,63 1765 -3400,61 2205 -10900,64 2800 -18800,62 3050 -20170,64 2785 -21800,63 2240 -21900,62 2030 -18900,65 1975 -30500,64 1030 -27500,62 910 -1470
![Page 29: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/29.jpg)
1- Is it used?
2- Why to use it ?
3- For whom?
4- How to prescribe it?
5- Which is the ideal dose ?
6- Is it better or worsen than other methods?
7- What is the real role of PD in AKI?
Peritoneal Dialysis in AKI
![Page 30: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/30.jpg)
Ideal dialysis dose in AKI is controversial
There are not studies that evaluated the effects ofdifferent PD doses on outcome of AKI patients
![Page 31: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/31.jpg)
• prospective and randomized study in India
• evaluated two modes of automatic PD (CPD and tidal)
• 87 patients with AKI and no severe catabolism
Total volume of dialysate per session was similar in two groups: 26 l
![Page 32: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/32.jpg)
Results and conclusions
Pre-dialysis BUN (mg/dL) 77.9 ± 22.1 78.8 ± 8.3 0.67
Post-dialysis BUN (mg/dl) 64.7 ± 12.4 50.8 ± 11.3 0.04
KT/V (session) 0.26 ± 0.07 0.34 ± 0.14 0.001
(week) 1.8 ± 0.32 2.43 ± 0.87 0.001
SRI (%) 20.6 ± 6 28.4 ± 4 0.02
UF (L/session) 2.01 ± 0.28 2.88 ± 0.7 0.03
Total protein loss (g/session) 6.6 ± 1.2 10.5 ± 1.5 0.001
Albumin loss (g/session) 3.48 ± 2.1 6.32 ± 1.03 0.02
CPD TPD p
“Both CPD and TPD are reasonable options for mil-moderate hyper catabolic ARF. TPDprovides better clearances at the same volume. Higher protein loss in TPD was the only
limitation to its use in ARF.”
![Page 33: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/33.jpg)
Prospective study with different doses of CPD (flexible catheter , cycler, 24 h 7 x a week)
Patients with AKI of ATN were randomly assigned to receive:
Lower intensity PD: prescribed Kt/V = 0.5 (n=60)
Higher intensity PD: prescribed Kt/V=0.8 per session (n=60)
In press
To evaluatevaluate thethe effectseffects ofof differentdifferent PD doses PD doses onon outcomeoutcome ofof AKI AKI patientspatients
This study was early interrupted because group assigned to higher intensitydialysis received lower dialysis dose than that prescribed.
Ponce D, Abrão JMG, Berbel MN, André Luis Balbi
![Page 34: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/34.jpg)
Ä
Table 1. Peritoneal Dialysis session characteristics
Ä
Characteristics Lower intensity Higher intensity
Kt/V=0.5 Kt/V=0.8
Ä
Dialysate fluid/cycle (l) 2.0 2..0
Inflow time (min) 10 10
Outflow time (min) 20 20
Dwell time (min) 45°©60 30-45
Duration /cycle (min) 75-90 60-75
Total exchanges/session 16-19 20-24
Total dialysate volum/session 32-38 40-48
Total duration of session (h) 24 24
Flow rate mL/minute 22-26.5 27.8-33.3
Glucose (%) 1.5-4.25 1.5-4.25Ä
Ä
Ä
Ä
Ponce D, Abrão JMG, Berbel MN, Balbi AL
![Page 35: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/35.jpg)
Patients Characterísticss
Characteristics Higher Lower p (n=31) (n=30)
Male (%) 71 65 0.58
Age (years) 64.2 ± 18.8 62.8 ± 16.2 0.32
Oliguria (%) 56 58 0.78
ATN-ISS 0.67 0.66 0.48
APACHE II 26.4 ± 6.9 24.8 ± 8.6 0.18
Sessions (number) 6.1 5.7 0.48
Pre BUN (mg/ 100 ml) 118.8± 32.6 114.2±34.8 0.78
Pre creat (mg/100 ml) 5.6 ± 1.9 5.8 ± 1.4 0.79
Cause of AKI (%)
Sepsis 48 50 0.77
Heart failure 25 22 0.58
Post-surgery 11 14 0.65
Etiology of ATN (%)
Ischemic 82 78 0.38
Mixed 16 20 0.61
Indication of dialysis (%)
Azotemia 64 66 0.78
Volume overload 20 18 0.84
Ponce D, Abrão JMG, Berbel MN, Balbi AL
Higher Lower p n=31 n=30
KT/V per session:
prescribed 0.8 0.5
delivered 0.59±0.1a 0.43±0.1 0.03weekly:
prescribed 5.6 3.5delivered 4.13±0.6a 3.43±0.2 0.03
UF per session (L) 2.41 ± 0,7 2.11 ± 0.6 0.42
a Significantly different from prescribed Kt/V (p=0.04)
Table 03. Weekly and per Session Kt/V and UKF inPatients undergoing higher and lower intensity PD dose
![Page 36: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/36.jpg)
0
20
40
60
80
100
120
140
BUN
(mg/
dl)
a. BUN (mg/dl)
0
1
2
3
4
5
6
7
Cr (m
g/dl
)
0
5
10
15
20
25
0
1
2
3
4
5
6
b. Creatinine (mg/dl)
c. Bicarbonate (mEq/L)d. Potassium (mEq/L)
Figure 3. Comparison of metabolic control in higher and lower-intensity peritoneal dialysis dose. Median serum levels of (a) BUN, (b)creatinine, (c) bicarbonate, (d) potassium, at the beginning of treatment and after each session.
Control metabolico
![Page 37: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/37.jpg)
Table 4. Outcomes according to treatment group
Higher Lower p value (n=31) (n=30)
Mortality (%) 55 53 0.83Recovery of kidney function (%)* 86 86 0.97Duration of treatment (days) 6.1± 2.7 5.7 ± 2.1 0.42
* Recovery and resolution of kidney function of survivors only
Fig 2. Comparison patient survival after 30 days treatment
Ponce D, Abrão JMG, Berbel MN, Balbi AL
![Page 38: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/38.jpg)
Conclusion
This study showed that increasing the intensity of continuous HVPD does not: :
reduce mortality or dependence on dialysis improve metabolic control among critically ill patients.
Peritoneal clearance is limited by: dialysate flow, membrane permeability, and area (KoA)
leading to a maximum delivered Kt/V of 0.6 per session
It suggests that prescribed Kt/V of 0.5 per session is enough to get a satisfactorymetabolic control and patient outcome
Ponce D, Abrão JMG, Berbel MN, Balbi AL
![Page 39: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/39.jpg)
1- Is it used?
2- Why to use it ?
3- For whom?
4- How to prescribe it?
5- Which is the ideal dose ?
6- Is it better or worsen than other methods?
7- What is the real role of PD in AKI?
Peritoneal Dialysis in AKI
![Page 40: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/40.jpg)
![Page 41: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/41.jpg)
• prospective and randomized study
• 2 groups: 70 patients (PD = 36 and HF= 34)
• protocol was discontinued: mortality rate > PD (RR=3.2)
N Engl J Med 2002;347:895-902
![Page 42: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/42.jpg)
Observations regarding results
PD
• rigid catheters
• manual exchanges
• dwell time < 15 min (70 l/day)
• no dialysis dose quantification
Daugirdas. NEJM, 2002Rao. PDI, 2003
Is not PD indicated in AKI ?
![Page 43: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/43.jpg)
Kid Int (2008) 73,S87-S93
![Page 44: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/44.jpg)
![Page 45: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/45.jpg)
![Page 46: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/46.jpg)
![Page 47: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/47.jpg)
PD DHD p
KT/V per session:
prescribed 0.65 1.2delivered 0.53 0.79 <0.01
weekly:prescribed 4.5 7.2delivered 3.51 4.8 <0.01
UFper session (L) 2.1 ± 0,7 2.4 ± 0,7 0.39
Complications (%)infectious 18 8.5 0.21mechanical 5 18 0.13
![Page 48: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/48.jpg)
30,0025,0020,0015,0010,005,000,00
Time ( days)
1,0
0,8
0,6
0,4
0,2
0,0
Su
rviv
al
(%)
DHD
HVPD
p = 0.48
Sobrevida en 30 días
![Page 49: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/49.jpg)
![Page 50: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/50.jpg)
High Volume PD x Extended Daily Hemodialysis in patients with AKI
AL Balbi, GA Brito, JMG Abrão, M Pinto, D Ponce
University Hospital, Botucatu School of Medicine, São Paulo, Brazil, 2008
• Prospective randomized trial
• 180 hemodynamically unstable AKI patients treated with HVPD or EDH
• Objectives are evaluate death within 60 days
recovery of kidney function metabolic control
From now: 64 patients in SLED and 48 patients in HVPD
Further Studies
![Page 51: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/51.jpg)
HVPD (48)SLED (64)Characteristics
Male (%) 70.1 70.8
age (years) 66.8 ± 10 58.9 ± 18
ATN-ISS (media) 0.63 0.72
Ischemic AKI (%) 89 83
BUN (mg/dl) 91 ± 30 96 ± 25
creatinine (mg/dl) 4.8 ± 1.5 5.7 ± 3.2
Table 1: Characteristics of patients
High Volume PD x Extended Daily Hemodialysis in patients with AKI
AL Balbi, GA Brito, JMG Abrão, M Pinto, D Ponce
mortality Recovery renalfunction (survival)
0
25
50
75
100%
76,1%
69,6%
81%87%
SLED HVPD
p>0.05
Mortality rate and recovery of renal function
HVPD and EDH can be effective and similar methods
for treating AKI patients
Conclusion
![Page 52: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/52.jpg)
1- Is it used?
2- Why to use it ?
3- For whom?
4- How to prescribe it?
5- Which is the ideal dose ?
6- Is it better or worsen than other methods?
7- What is the real role of PD in AKI?
Peritoneal Dialysis in AKI
![Page 53: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/53.jpg)
it is an important therapeutic alternative for a selected group of patients, manly in developing countries
to overcome limitations, it must be carried in continuous and
automatic method with high volume of dialysate
prescription should be individual to achieve adequate solute and
fluid control
Kt/V =0.5 per session seems to be enough
There is room for a more frequent use of PD in AKI
In press
Ponce D, Balbi AL
Peritoneal Dialysis in Acute Kidney Injury: a Viable Alternative
![Page 54: Therapeutic Modalities: CRRT, SLED, PD PDcrrtonline.com/conference/CRRT11_PresPDFs/Ponce_100_G15TheraMods.pdf · Therapeutic Modalities: CRRT, SLED, PD PD ... HC - SP Lima EQ. ASN,](https://reader031.vdocument.in/reader031/viewer/2022021910/5bfe6a8109d3f2ff098b5b2d/html5/thumbnails/54.jpg)
André Luis Balbi
Germana Alves de Brito
Juliana Gera Abrão
Marina Nogueira Berbel
Milene Perón Rodrigues
Laudilene R Marinho
Cibele T. P. Almeida
Andréa V. Hecker
Elza Maria Januário
Ana Cristina Paulino Leite
BOTUCATU SCHOOL OF MEDICINE, SAO PAULO STATE, BRAZIL